The nuclear receptor TR4 binding protein, TRA16, has been implicated in lung carcinogenesis; however, its broader role across diverse human cancers remains poorly understood.
Understanding TRA16's involvement in cancer biology could uncover novel regulatory mechanisms and potential therapeutic targets.
